secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2025-05-20T23:59:59+00:00
Accession:  0001837607-25-000055
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AEON Biopharma presents corporate update at Aegis Capital Conference, focusing on PrabotulinumtoxinA
--------------------------------------------------------------------------------

- Presentation highlights PrabotulinumtoxinA as a therapeutic botulinum toxin product candidate.
- Corporate presentation made available on AEON's investor relations website on May 20, 2025.
- No specific clinical data, financial results, or material changes disclosed in the furnished slides.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000183760725000055/0001837607-25-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000183760725000055/aeon-20250520x8k.htm
  HTML page:      https://secwatch.observer/filing/0001837607-25-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer